Apelin and Its Relation with Glucose Metabolism in Adolescents with Type 1 Diabetes Mellitus: Comparative Study

Abstract

Background: Type 1 diabetes mellitus, also known as insulin-dependent diabetes, characterized by elevated levels of blood glucose (hyperglycemia), which produced by the autoimmune destruction of pancreatic islet β-cells insulin-producing. Objective: This study aimed to examine the alterations in Apelin, Lipid profiles, fasting blood glucose, HbA1C, calcium, parathyroid hormone and vitamin D in adolescents with type 1 diabetic and healthy adolescents. Methods: This study was done in the Maternity and Children Teaching Hospital and Al-Ramadi Teaching Hospital in Ramadi city in Iraq, between January 2024 to July 2024. One hundred adolescents were selected: 60 patients with diabetes and 40 healthy as a control group. Biochemical tests for blood samples were performed. Results: The results showed there was a significantly increase in concentrations of Apelin, lipid profile (except high-density lipoprotein cholesterol), fasting blood glucose, HbA1C and calcium in patients with diabetes than control group. Whereas, there was a significantly reduction in concentration of the high-density lipoprotein cholesterol, parathyroid hormone and vitamin D in patients with diabetes than  control group. The results showed a significant positive correlation among glucose concentrations and Apelin concentrations, while there was a significant inverse relationship between blood parathyroid hormone and blood glucose concentrations, and also, there was a significant inverse relationship between vitamin D concentration and HbA1c. Conclusion: The high serum concentrations of Apelin in diabetic patients supports the function of Apelin in diabetes mellitus development and highlight the utilize of Apelin as a medical sign in diabetes

Similar works

This paper was published in Journals of University of Babylon.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.

Licence: http://creativecommons.org/licenses/by/4.0